Kestra Private Wealth Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Kestra Private Wealth Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,048	Closed	-$206K	–	1172
2023 Q2	$206K	Buy	+6,048	New	+$190K	0.01%	957
2023 Q1	–	Sell	-7,333	Closed	-$207K	–	1061
2022 Q4	$207K	Sell	7,333 -2,447	-25%	-$77.7K	0.01%	792
2022 Q3	$321K	Sell	9,780 -4,434	-31%	-$163K	0.02%	626
2022 Q2	$448K	Sell	14,214 -5,636	-28%	-$197K	0.03%	538
2022 Q1	$912K	Sell	19,850 -1,457	-7%	-$69.5K	0.05%	399
2021 Q4	$1.3M	Sell	21,307 -80	-0.4%	-$5.53K	0.06%	320
2021 Q3	$1.6M	Buy	21,387 +9,327	+77%	+$783K	0.09%	250
2021 Q2	$1.12M	Buy	12,060 +420	+4%	+$35.7K	0.07%	307
2021 Q1	$1.03M	Buy	11,640 +5,439	+88%	+$540K	0.07%	286
2020 Q4	$596K	Buy	6,201 +2,354	+61%	+$188K	0.04%	395
2020 Q3	$245K	Buy	+3,847	New	+$225K	0.02%	548

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Kestra Private Wealth Services's ARKG Position: Q3 2023 in Review

Kestra Private Wealth Services sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 6,048 shares — an estimated $206K sold.

Kestra Private Wealth Services first reported a position in ARKG in Q3 2020 and held it in 11 quarters. The position peaked at $1.6M in Q3 2021. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

Kestra Private Wealth Services reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
Kestra Private Wealth Services sold 6,048 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $206K.
Kestra Private Wealth Services first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 11 quarters.
Kestra Private Wealth Services's ARK Genomic Revolution ETF position peaked at $1.6M in Q3 2021.
286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Kestra Private Wealth Services's 13F filing for Q3 2023, filed 8 Nov 2023.